Thermo Fisher Scientific
TMO
TMO
2,381 hedge funds and large institutions have $178B invested in Thermo Fisher Scientific in 2023 Q2 according to their latest regulatory filings, with 148 funds opening new positions, 920 increasing their positions, 955 reducing their positions, and 124 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
10.56% less ownership
Funds ownership: 99.92% → 89.36% (-11%)
12% less call options, than puts
Call options by funds: $1.16B | Put options by funds: $1.31B
34% less funds holding in top 10
Funds holding in top 10: 212 → 139 (-73)
Holders
2,381
Holding in Top 10
139
Calls
$1.16B
Puts
$1.31B
Top Buyers
| 1 | +$1.68B | |
| 2 | +$1.26B | |
| 3 | +$987M | |
| 4 |
PG
Prostatis Group
Hanover,
Maryland
|
+$782M |
| 5 |
Morgan Stanley
New York
|
+$420M |
Top Sellers
| 1 | -$21.8B | |
| 2 | -$2.2B | |
| 3 | -$1.16B | |
| 4 |
Jennison Associates
New York
|
-$858M |
| 5 |
BlackRock
New York
|
-$744M |